Published in Breast Cancer Weekly, April 8th, 2000
After having suggested in a previous study that PTA levels in primary breast tumors be used to identify patients at high risk for distant metastasis, C. Magdalena and colleagues designed another study to examine the role of PTA levels in relation to disease-free survival (DFS) and survival. Their findings were published in British Journal of Cancer ("Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer," Br J Cancer,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Breast Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.